Compound Identification Development Cores (U2C)
Funding Opportunity RFA-RM-17-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish Compound Identification Development Cores (CIDC) to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites. The ultimate goal of this FOA is to expand the repertoire of biologically relevant compounds that can be quickly and inexpensively identified in high throughput metabolomics experiments. An interdisciplinary approach and partnership among metabolomics experts, biomedical researchers, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2017 Category: Research Source Type: funding
Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. Th...
Source: NIDDK Funding Opportunities - August 1, 2017 Category: Endocrinology Source Type: funding
Dear Colleague Letter: Removal of Deadlines for the Combustion and Fire Systems Program in the Division of Chemical, Biological, Environmental, and Transport Systems in the Directorate for Engineering
Available Formats: HTML: https://www.nsf.gov/pubs/2017/nsf17117/nsf17117.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2017/nsf17117/nsf17117.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf17117Public Comment: Related Frequently Asked Questions (FAQs) NSF 17-118.This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 31, 2017 Category: Science Source Type: funding
Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
Funding Opportunity PAR-17-438 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), NIH wishes to stimulate research in discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes; and to generate new insight into the biology of relevant diseases and processes that have yet to be validated as important drug targets. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 27, 2017 Category: Research Source Type: funding
Dear Colleague Letter: Removal of Deadlines for the Process Separations Program in the Division of Chemical, Biological, Environmental, and Transport Systems in the Directorate for Engineering
Available Formats: HTML: https://www.nsf.gov/pubs/2017/nsf17114/nsf17114.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2017/nsf17114/nsf17114.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf17114This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 24, 2017 Category: Science Source Type: funding
Discovery of cell-based Chemical Probes for Novel Brain Targets (R21)
Funding Opportunity PAR-17-335 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in: 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2017 Category: Research Source Type: funding
Discovery of in vivo Chemical Probes for Novel Brain Targets (R01)
Funding Opportunity PAR-17-336 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2017 Category: Research Source Type: funding
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
Funding Opportunity PAR-17-331 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack cancer cells. These small molecules could be further developed into stand-alone immunotherapeutics or synergistic partners for existing therapies, or as chemical probes for the discovery and validation of novel targets involved in anti-tumor immunity. Investigators from multiple scientific disciplines (immuno-oncology, tumor biology, screening technol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2017 Category: Research Source Type: funding
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
Funding Opportunity PA-17-330 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity (FOA) is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus of this FOA is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2017 Category: Research Source Type: funding
Notice of NIDA's Participation in PAR-15-315 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)"
Notice NOT-DA-17-046 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2017 Category: Research Source Type: funding
BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21)
Funding Opportunity RFA-EY-17-002 from the NIH Guide for Grants and Contracts. A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some understanding, they may not be sufficient to accomplish this goal. For example, non-invasive technologies are low resolution and/or provide indirect measures such as blood flow, which are imprecise; invasive technologies can provide information at the level of single neurons producing the fundamental b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2017 Category: Research Source Type: funding
Notice of NIDA's Participation in PAR-16-330 "Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)"
Notice NOT-DA-17-047 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2017 Category: Research Source Type: funding
Notice of NIDA's Participation in PAR-16-331 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)"
Notice NOT-DA-17-048 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2017 Category: Research Source Type: funding
Dear Colleague Letter: Data-Driven Discovery Science in Chemistry (D3SC)
Available Formats: HTML: https://www.nsf.gov/pubs/2017/nsf17112/nsf17112.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2017/nsf17112/nsf17112.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf17112This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 14, 2017 Category: Science Source Type: funding
BNSF Railway Foundation Grants
Offers grants to organizations that operate near a BNSF railway line. Among others, priority areas include health and human service organizations, programs that address chemical dependency treatment and prevention, spouse and child abuse, women's and children's aid, transitional shelters, hospitals, medical programs, and youth development programs. Geographic coverage: Nationwide -- BNSF Railway Foundation (Source: Children funding opportunities via the Rural Assistance Center)
Source: Children funding opportunities via the Rural Assistance Center - July 3, 2017 Category: Child Development Source Type: funding
